Form 4 · Filed Jun 22, 2026, 08:09 PM UTC
AKBA/Akebia Therapeutics, Inc.
ADAMS ADRIAN — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | A | other | 35,700 | $0 | $0 | 236,200 |
| Jun 17, 2026 | A | other | 53,600 | — | — | 53,600 |
Source: SEC EDGAR raw filing ↗ · Accession 0001248144-26-000001